Review Article

Volume: 3 | Issue: 1 | Published: May 20, 2020 | Pages: 14 - 21 | DOI: 10.24911/JBCGenetics/183-1585310179

Prevalence of neurometabolic diseases in Saudi Arabia


Authors: Mohammed Almuqbil


Article Info

Authors

Mohammed Almuqbil

College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Riyadh, Saudi Arabia

Publication History

Received: March 27, 2020

Accepted: May 15, 2020

Published: May 20, 2020


Abstract


Neurometabolic disorders are most often seen in newborns and infants and have come to be recognized as an important group of disorders. Understanding diagnostic and therapeutic developments in neurometabolic disorders requires a concrete understanding of the classical principles of inborn errors of metabolism in order to provide key constructs for a fundamental understanding of this interesting category of disorders. The Saudi Arabian population has a comparatively high incidence of neurometabolic disorders, primarily due to consanguinity (with a high inbreeding coefficient factor) and large family sizes. The most frequently occurring group of disorders are lysosomal storage diseases, followed by organic acidemias; intellectual disability and cerebral palsy are the most commonly presented neurological features among Saudi Arabian children. This review summarizes the reports and studies of neurometabolic disorders prevalent in Saudi Arabia. It presents an overview of the types of disorders, current screening and diagnostic strategies, and prevalence of disease conditions in Saudi Arabia.

Keywords: Neurometabolism, neurogenetics, Saudi Arabia


Pubmed Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBC Genetics. 2020; 20 (May 2020): 14-21. doi:10.24911/JBCGenetics/183-1585310179

Web Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. https://jbcgenetics.com/articles/2146 [Access: June 02, 2025]. doi:10.24911/JBCGenetics/183-1585310179

AMA (American Medical Association) Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBC Genetics. 2020; 20 (May 2020): 14-21. doi:10.24911/JBCGenetics/183-1585310179

Vancouver/ICMJE Style

Mohammed Almuqbil. Prevalence of neurometabolic diseases in Saudi Arabia. JBC Genetics. (2020), [cited June 02, 2025]; 20 (May 2020): 14-21. doi:10.24911/JBCGenetics/183-1585310179

Harvard Style

Mohammed Almuqbil (2020) Prevalence of neurometabolic diseases in Saudi Arabia. JBC Genetics, 20 (May 2020): 14-21. doi:10.24911/JBCGenetics/183-1585310179

Chicago Style

Mohammed Almuqbil. "Prevalence of neurometabolic diseases in Saudi Arabia." 20 (2020), 14-21. doi:10.24911/JBCGenetics/183-1585310179

MLA (The Modern Language Association) Style

Mohammed Almuqbil. "Prevalence of neurometabolic diseases in Saudi Arabia." 20.May 2020 (2020), 14-21. Print. doi:10.24911/JBCGenetics/183-1585310179

APA (American Psychological Association) Style

Mohammed Almuqbil (2020) Prevalence of neurometabolic diseases in Saudi Arabia. , 20 (May 2020), 14-21. doi:10.24911/JBCGenetics/183-1585310179